why choose us

First received: January 19, 2023

Clinical Trial: Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases

Study Status: Completed

Recruit Status: RECRUITING

Condition: Melanoma (Skin)

Study Type: INTERVENTIONAL


Official Title: Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases

Brief Summary: To learn if giving nivolumab in combination with relatlimab can help to control melanoma that has spread to the brain (melanoma with brain metastases).The safety and side effects of the study drug combination will also be studied.

Read more